NASDAQ:SIBN SI-BONE (SIBN) Stock Forecast, Price & News $24.27 -0.27 (-1.10%) (As of 05/26/2023 04:00 PM ET) Add Compare Share Share Today's Range$24.07▼$24.6750-Day Range$19.28▼$26.4952-Week Range$11.14▼$27.24Volume202,100 shsAverage Volume331,633 shsMarket Capitalization$853.82 millionP/E RatioN/ADividend YieldN/APrice Target$25.29 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability SI-BONE MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside4.2% Upside$25.29 Price TargetShort InterestHealthy2.24% of Shares Sold ShortDividend StrengthN/ASustainability-1.44Upright™ Environmental ScoreNews Sentiment1.49Based on 4 Articles This WeekInsider TradingSelling Shares$7.45 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.44) to ($1.26) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.37 out of 5 starsMedical Sector268th out of 1,010 stocksSurgical & Medical Instruments Industry27th out of 104 stocks 2.5 Analyst's Opinion Consensus RatingSI-BONE has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $25.29, SI-BONE has a forecasted upside of 4.2% from its current price of $24.27.Amount of Analyst CoverageSI-BONE has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.24% of the outstanding shares of SI-BONE have been sold short.Short Interest Ratio / Days to CoverSI-BONE has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SI-BONE has recently decreased by 28.47%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSI-BONE does not currently pay a dividend.Dividend GrowthSI-BONE does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSI-BONE has received a 34.81% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Cervical implants" product. See details.Environmental SustainabilityThe Environmental Impact score for SI-BONE is -1.44. Previous Next 4.2 News and Social Media Coverage News SentimentSI-BONE has a news sentiment score of 1.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for SI-BONE this week, compared to 2 articles on an average week.Search Interest11 people have searched for SIBN on MarketBeat in the last 30 days. MarketBeat Follows2 people have added SI-BONE to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SI-BONE insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,452,628.00 in company stock.Percentage Held by InsidersOnly 5.40% of the stock of SI-BONE is held by insiders.Percentage Held by Institutions98.03% of the stock of SI-BONE is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for SI-BONE are expected to grow in the coming year, from ($1.44) to ($1.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SI-BONE is -15.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SI-BONE is -15.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSI-BONE has a P/B Ratio of 8.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About SI-BONE (NASDAQ:SIBN) StockSI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 2008 and is headquartered in Santa Clara, CA.Read More Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter. Email Address SIBN Stock News HeadlinesMay 29, 2023 | finance.yahoo.comDespite shrinking by US$86m in the past week, SI-BONE (NASDAQ:SIBN) shareholders are still up 69% over 1 yearMay 24, 2023 | finance.yahoo.comSI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023May 29, 2023 | Stocks To Trade (Ad)Free A.I. Trade Alerts. Up to 15 opportunities a day.Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 21, 2023 | americanbankingnews.comAnthony J. Recupero Sells 5,459 Shares of SI-BONE, Inc. (NASDAQ:SIBN) StockMay 20, 2023 | americanbankingnews.comAnshul Maheshwari Sells 3,624 Shares of SI-BONE, Inc. (NASDAQ:SIBN) StockMay 20, 2023 | americanbankingnews.comSI-BONE, Inc. (NASDAQ:SIBN) CEO Laura Francis Sells 9,009 SharesMay 14, 2023 | americanbankingnews.comSI-BONE, Inc. (NASDAQ:SIBN) Receives Average Rating of "Buy" from BrokeragesMay 11, 2023 | americanbankingnews.comSI-BONE, Inc. (NASDAQ:SIBN) Director Jeffrey W. Dunn Sells 272,753 SharesMay 29, 2023 | Stocks To Trade (Ad)Free A.I. Trade Alerts. Up to 15 opportunities a day.Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 10, 2023 | msn.comUnusual Call Option Trade in SI-BONE (SIBN) Worth $65.00KMay 6, 2023 | americanbankingnews.comNeedham & Company LLC Increases SI-BONE (NASDAQ:SIBN) Price Target to $27.00May 5, 2023 | americanbankingnews.comCantor Fitzgerald Comments on SI-BONE, Inc.'s FY2023 Earnings (NASDAQ:SIBN)May 4, 2023 | americanbankingnews.comSI-BONE (NASDAQ:SIBN) PT Raised to $28.00 at Truist FinancialMay 4, 2023 | americanbankingnews.comSI-BONE (NASDAQ:SIBN) Shares Gap Up on Analyst UpgradeMay 3, 2023 | americanbankingnews.comSI-BONE (NASDAQ:SIBN) Reaches New 1-Year High at $22.73May 2, 2023 | finance.yahoo.comWhy Shares of Si-Bone Jumped TuesdayApril 30, 2023 | americanbankingnews.comSI-BONE (SIBN) Set to Announce Earnings on MondayApril 24, 2023 | finance.yahoo.comSI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare ConferenceApril 18, 2023 | finance.yahoo.comWhy We're Not Concerned About SI-BONE, Inc.'s (NASDAQ:SIBN) Share PriceApril 17, 2023 | americanbankingnews.comAnalysts Set SI-BONE, Inc. (NASDAQ:SIBN) Target Price at $24.63April 10, 2023 | finance.yahoo.comSI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023April 9, 2023 | americanbankingnews.comFinancial Survey: SI-BONE (NASDAQ:SIBN) vs. Glaukos (NYSE:GKOS)April 7, 2023 | americanbankingnews.comAnshul Maheshwari Sells 1,229 Shares of SI-BONE, Inc. (NASDAQ:SIBN) StockApril 7, 2023 | americanbankingnews.comAnthony J. Recupero Sells 1,712 Shares of SI-BONE, Inc. (NASDAQ:SIBN) StockMarch 29, 2023 | americanbankingnews.comShort Interest in SI-BONE, Inc. (NASDAQ:SIBN) Decreases By 24.3%March 24, 2023 | americanbankingnews.comSI-BONE (NASDAQ:SIBN) and Invo Bioscience (OTCMKTS:IVOB) Head-To-Head ContrastMarch 23, 2023 | americanbankingnews.comSI-BONE, Inc. (NASDAQ:SIBN) Receives $24.63 Average Price Target from AnalystsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter. Email Address SIBN Company Calendar Last Earnings11/08/2021Today5/29/2023Next Earnings (Estimated)8/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SIBN CUSIPN/A CIK1459839 Webwww.si-bone.com Phone(408) 207-0700FaxN/AEmployees352Year Founded2008Price Target and Rating Average Stock Price Forecast$25.29 High Stock Price Forecast$32.00 Low Stock Price Forecast$20.00 Forecasted Upside/Downside+4.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-61,260,000.00 Net Margins-47.11% Pretax Margin-47.11% Return on Equity-54.17% Return on Assets-34.85% Debt Debt-to-Equity Ratio0.38 Current Ratio7.72 Quick Ratio6.65 Sales & Book Value Annual Sales$106.41 million Price / Sales8.02 Cash FlowN/A Price / Cash FlowN/A Book Value$2.85 per share Price / Book8.52Miscellaneous Outstanding Shares35,180,000Free Float33,284,000Market Cap$853.82 million OptionableNot Optionable Beta0.95 Social Links Key ExecutivesLaura A. FrancisChief Executive Officer & DirectorAnshul MaheshwariChief Financial & Accounting OfficerScott A. YerbyChief Technology Officer & Senior VP-EngineeringW. Carlton RecklingChief Medical Officer & VP-Medical AffairsJoyce GotoVice President & ControllerKey CompetitorsLongview Acquisition Corp. IINYSE:LGVCardiovascular SystemsNASDAQ:CSIINevroNYSE:NVROAtrionNASDAQ:ATRIOrthoPediatricsNASDAQ:KIDSView All CompetitorsInsiders & InstitutionsRoyce & Associates LPBought 36,000 shares on 5/23/2023Ownership: 0.375%Ameriprise Financial Inc.Sold 18,751 shares on 5/22/2023Ownership: 0.387%New York State Common Retirement FundSold 25,683 shares on 5/18/2023Ownership: 1.159%JPMorgan Chase & Co.Bought 14,700 shares on 5/18/2023Ownership: 0.683%First Light Asset Management LLCBought 8,759 shares on 5/16/2023Ownership: 6.009%View All Insider TransactionsView All Institutional Transactions SIBN Stock - Frequently Asked Questions Should I buy or sell SI-BONE stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SIBN shares. View SIBN analyst ratings or view top-rated stocks. What is SI-BONE's stock price forecast for 2023? 7 Wall Street research analysts have issued 12 month price objectives for SI-BONE's shares. Their SIBN share price forecasts range from $20.00 to $32.00. On average, they predict the company's share price to reach $25.29 in the next year. This suggests a possible upside of 4.2% from the stock's current price. View analysts price targets for SIBN or view top-rated stocks among Wall Street analysts. How have SIBN shares performed in 2023? SI-BONE's stock was trading at $13.60 at the beginning of 2023. Since then, SIBN stock has increased by 78.5% and is now trading at $24.27. View the best growth stocks for 2023 here. Are investors shorting SI-BONE? SI-BONE saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 786,800 shares, a decrease of 28.5% from the April 30th total of 1,100,000 shares. Based on an average daily trading volume, of 395,700 shares, the short-interest ratio is presently 2.0 days. View SI-BONE's Short Interest. When is SI-BONE's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023. View our SIBN earnings forecast. How were SI-BONE's earnings last quarter? SI-BONE, Inc. (NASDAQ:SIBN) announced its earnings results on Monday, November, 8th. The company reported ($0.48) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by $0.06. The company earned $22.29 million during the quarter, compared to the consensus estimate of $22.71 million. SI-BONE had a negative net margin of 47.11% and a negative trailing twelve-month return on equity of 54.17%. During the same period in the previous year, the business posted ($0.33) earnings per share. What ETFs hold SI-BONE's stock? ETFs with the largest weight of SI-BONE (NASDAQ:SIBN) stock in their portfolio include Hypatia Women CEO ETF (WCEO), Invesco Nasdaq Future Gen 200 ETF (QQQS), SPDR S&P Health Care Equipment ETF (XHE), Principal Healthcare Innovators ETF (BTEC), BlackRock Future Health ETF (BMED) and iShares Micro-Cap ETF (IWC).iShares U.S. Medical Devices ETF (IHI) and What guidance has SI-BONE issued on next quarter's earnings? SI-BONE issued an update on its FY 2023 earnings guidance on Monday, May, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $128.00 million-$131.00 million, compared to the consensus revenue estimate of $125.45 million. What is Jeffrey Dunn's approval rating as SI-BONE's CEO? 10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of SI-BONE own? Based on aggregate information from My MarketBeat watchlists, some companies that other SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), Raytheon Technologies (RTX), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO) and CSX (CSX). When did SI-BONE IPO? (SIBN) raised $84 million in an IPO on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. What is SI-BONE's stock symbol? SI-BONE trades on the NASDAQ under the ticker symbol "SIBN." Who are SI-BONE's major shareholders? SI-BONE's stock is owned by many different institutional and retail investors. Top institutional shareholders include Brown Advisory Inc. (11.24%), BlackRock Inc. (7.82%), First Light Asset Management LLC (6.01%), Champlain Investment Partners LLC (4.85%), Granahan Investment Management LLC (3.35%) and Next Century Growth Investors LLC (3.23%). Insiders that own company stock include Anshul Maheshwari, Anthony J Recupero, Anthony J Recupero, Gregory K Hinckley, Jeffrey W Dunn, Jeffrey W Dunn, Jeryl L Hilleman, Jeryl L Hilleman, John Gordon Freund, Laura Francis, Michael A Pisetsky and Michael A Pisetsky. View institutional ownership trends. How do I buy shares of SI-BONE? Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is SI-BONE's stock price today? One share of SIBN stock can currently be purchased for approximately $24.27. How much money does SI-BONE make? SI-BONE (NASDAQ:SIBN) has a market capitalization of $853.82 million and generates $106.41 million in revenue each year. The company earns $-61,260,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. How many employees does SI-BONE have? The company employs 352 workers across the globe. Does SI-BONE have any subsidiaries? The following companies are subsidiares of SI-BONE: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD.Read More How can I contact SI-BONE? SI-BONE's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The official website for the company is www.si-bone.com. The company can be reached via phone at (408) 207-0700 or via email at investors@si-bone.com. This page (NASDAQ:SIBN) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.